We are live on ! Find out more
LEXX icon

Lexaria Bioscience
LEXX

9 hedge funds and large institutions have $1.78M invested in Lexaria Bioscience in 2021 Q1 according to their latest regulatory filings, with 9 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

6.24% more ownership

Funds ownership: 0% → 6.24% (+6.2%)

Holders
9
Holders Change
+9
Holders Change %
–
% of All Funds
0.16%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
ICM
Invenomic Capital Management
Massachusetts
+$1.73M
2
Citadel Advisors
Citadel Advisors
Florida
+$87.4K
3
EWM
Edge Wealth Management
New York
+$19.5K
4
MFM
MD Financial Management
Ontario, Canada
+$15.7K
5
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$4.13K

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
ICM
1
Invenomic Capital Management
Massachusetts
$1.66M +$1.73M +296,101 New
Citadel Advisors
2
Citadel Advisors
Florida
$84K +$87.4K +14,915 New
EWM
3
Edge Wealth Management
New York
$19K +$19.5K +3,333 New
MFM
4
MD Financial Management
Ontario, Canada
$15K +$15.7K +2,686 New
Royal Bank of Canada
5
Royal Bank of Canada
Ontario, Canada
$4K +$4.13K +705 New
Bank of America
6
Bank of America
North Carolina
$1K +$850 +145 New
Osaic Holdings
7
Osaic Holdings
Arizona
$1K +$973 +166 New
Wells Fargo
8
Wells Fargo
California
– +$170 +29 New
Bank of Montreal
9
Bank of Montreal
Ontario, Canada
– +$193 +33 New

LEXX Hedge Fund Activity: Q1 2021 in Review

9 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Lexaria Bioscience (LEXX) for Q1 2021, worth a combined $1.78M.

Buyers outnumbered sellers: 9 funds opened new LEXX positions and 0 closed out — a net gain of 9 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Invenomic Capital Management, opening a new position worth an estimated $1.73M.

  • 9 institutional investors held Lexaria Bioscience (LEXX) as of Q1 2021, up from 0 in Q4 2020.
  • Funds reported $1.78M of Lexaria Bioscience stock for Q1 2021.
  • 9 funds opened new Lexaria Bioscience positions in Q1 2021 and 0 closed out, a net change of +9 holders.
  • The largest Lexaria Bioscience buyer in Q1 2021 was Invenomic Capital Management, an estimated $1.73M added.

Based on aggregated 13F filings for Q1 2021.